Strong Fourth Quarter and Full Year Results as Latham Continued to Outperform the U.S. In-Ground Pool Market Year-on-Year ...

LVEF (Left Ventricular Ejection Fraction): Percentage measure of how much blood the left ventricle pumps out with each ...

Good afternoon, everyone. Welcome to Gap Inc.'s Fourth Quarter Fiscal 2025 Earnings Conference Call. Before we begin, I'd like to remind you that the information made available on this conference call ...

Welcome to StoneCo's Fourth Quarter and Fiscal Year 2025 Earnings Conference Call. By now, everyone should have access to our earnings release. The company also posted a presentation to go along with ...

Strategic leadership changes -- Eran Ophir became CEO in September 2025, with Anat Cohen-Dayag transitioning to Executive Chair to enhance operational focus and strategic continuity.

Cumberland to highlight 2025 financial, international, portfolio and clinical progressNASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cumberland ...

The MarketWatch News Department was not involved in the creation of this content.-- FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance -- Lif ...

Bioventus Inc. (NASDAQ:BVS) Q4 2025 Earnings Call Transcript March 5, 2026 Bioventus Inc. misses on earnings expectations. Reported EPS is $0.2141 EPS, expectations were $0.22. Operator: Good day, and ...

Compugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call Transcript March 2, 2026 Compugen Ltd. beats earnings expectations. Reported EPS is $0.6, expectations were $0.05. Operator: Ladies and gentlemen, ...

American Eagle Outfitters, Inc. (NYSE: AEO) today announced financial results for the fourth quarter and fiscal year ended January 31, 2026, and provided its outlook for fiscal year 2026.

StubHub Holdings, Inc. (NYSE:STUB) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to StubHub’s Fourth Quarter and Year-End ...

Cumberland to highlight 2025 financial, international, portfolio and clinical progress NASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.